From June 15 to June 18, 2015, swissnex Boston had the pleasure to be an integral part of the Swiss Biotech Pavilion at the BIO International Convention 2015 in Philadelphia. The convention featured more than 1,700 exhibitors on approximately 14,900 square meters. Within the Swiss Biotech Pavilion, we assembled the Swiss Startup Corner and brought together 10, among startups and Swiss institutions, currently catalyzing Biomedical innovation in Switzerland (For a complete list of the participants, please see section below). All participants could profit of the one-to-one partnering system to initiate important business development collaborations. 6 of the companies were part of the Swiss National Startup Team, and were already in the US to go through the 10 day venture leaders program, which started in Boston on June 9 and ended in New York City on June 19. The 6 entrepreneurs participated in a pitch competition at the University Science Center in Philadelphia on June 17, where they were challenged by Philadelphia based entrepreneurs and a jury of investors. Ruben, from Polyneuron and Chris, from Cellspring, both Swiss, won the competition. The event was also an opportunity to launch the collaboration between the University Science Center and the Swiss based Y parc, represented in the competition by Yannick Charrotton, CTO of Lambda Health Systems, a robotic company specialized in rehabilitation systems.
The Swiss Startup Corner was possible also thanks to the generous contribution of the Commission for Technology and Innovation of the Swiss Government (CTI), which is providing several instruments to Swiss startups, when it comes to internationalization. In the US, the swissnex team, together with CTI, is running the US market entry camps, programs which have already supported and given unparalleled competitive advantage to some of the most innovative startups emerged from our small country in the hearth of Europe. 3 of the startups present at the Swiss Startup Corner, PIQUR, inSphero and NBE-Therapeutics, were CTI labelled, an important recognition that the CTI provides to startups having gone through a really intensive coaching and maturation program back in Switzerland.
If you wish to learn more about swissnex Boston, our activities in innovation and entrepreneurship or about the participants at the Swiss Startup Corner at BIO 2015, please contact Niccolo Iorno, Project Leader Innovation @ swissnex Boston: email@example.com.
CellSpring: Chris Millan; CTO
Rqmicro Gmbh: Hans-Anton Keserue; CEO
SimplicityBio: Miguel Barreto; CEO
Polyneuron Pharmaceuticals AG : Ruben Herrendorff ; CEO
HYLOMORPH AG : Simone Bottan; CEO
ZuriMED Technologies: Xiang Li; CEO
PIQUR Therapeutics AG: Herve Girsault; CBO
NBE-Therapeutics AG: Ulf Grawunder; CEO
InSphero: Stewart Hunt; Director North American Business Development
Wyss Institute Zurich: Michael Stucky; COO
swissnex Boston: Felix Moesner, CEO; Niccolo Iorno, PL innovation; Francesca Cerza, Junior PM innovation.